Form D · Pharmaceuticals
MODULO BIO, INC.
Los Altos, CA · CIK 0001867562
Offering snapshot reported Nov 20, 2024 · SEC filing
- Reported sold
- $5.85M Offering amount: $7.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 6, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 20, 2024 | Initial | $5,845,788 | No comparison | 3 | SEC filing |
| Jun 15, 2021 | Initial | $3,909,992 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-529932
Source: Form D, filed Nov 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alda Leu Dennis | Director |
| Michael Horowitz | Director, Executive |
| Alexander Scott Patterson | Director |
| Nicholas Saccomano | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1525 Kensington
Los Altos, CA, 94024
Los Altos, CA, 94024